Calmark: Calmark's Neo instrument is registered in India

Press release from Companies

Publicerat: 2023-01-19 14:31:29

Calmark Sweden AB: Calmark's Neo instrument is registered in India

Calmark Sweden AB (publ) announced today that the company's instrument for analyzing point-of-care tests, POC-Analyzer Neo, has been registered by the Indian authorities. Associated test for measuring bilirubin in the blood of newborns, Neo-Bilirubin, is still under registration process.

Registration of medical devices is mandatory before the sales start.

Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.

For more information about Calmark Sweden AB, please contact:

Camilla Arneving, Acting CEO
Telefon: [phone]
E-post: [e-mail]
www.calmark.se

Calmark Sweden AB is a medical technology company that manufactures and markets a point-of-care (POC) analysis method with easier and faster diagnostics of medical conditions in newborns. The unique test platform consists of a portable instrument and test cassettes for various biomarkers. The first test, Neo-Bilirubin, is CE marked and measures the bilirubin level in whole blood for jaundice detection in newborns. In the Western world, the introduction of POC diagnostics is resulting in huge savings and shorter care chains. In less developed healthcare systems, the product offers a decision support which is currently lacking, since the access to hospital laboratories often is limited. Calmark aims to become the global leader in POC diagnostics for newborns and, in the long term, to offer all relevant tests for the first period of life. The B share is listed on the Spotlight Stock Market and is traded under the CALMA B ticker.Read more at www.calmark.se/eng/home.

Read as PDF

Release